The thyroid hormone receptor (THR) is a type of nuclear receptor which belongs to a superfamily of eukaryotic transcription factors. It regulates gene expression in response to binding small, hydrophobic ligands. The receptors exhibits a modular structure, with functionally separable domains. The most highly conserved domains are the DNA-binding domain (DBD) and the ligand-binding domain (LBD). The DBD recognizes the specific DNA responses element for the receptor. The LBD participates in several activities, including hormone binding, homo-and/or heterodimerization, formation of heat-shock-protein complex, and transcriptional activation and repression. Unliganded thyroid hormone receptors are bound to DNA thyroid hormone response elements predominantly as homodimers, or as heterodimers with retinoid X-receptors, and are associated with a complex of proteins containing corepressor proteins. Ligand binding promotes corepressor dissociation and binding of a coactivator. Hormone binding induces changes in receptor conformation that control these properties and influence gene expression. www.MedChemExpress.com
Abaloparatide TFA (BA 058 TFA) is a parathyroid analogue selected to hormone receptor 1 (PTHR1) be a potent and selective activator of the PTHR1 signaling pathway.
Purity:
96.08% Clinical Data: Size:
10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg CO23 Cat. No.: HY-130012 CO23 is a selective thyroid hormone receptor (TR) agonist and used for growth and development α regulation. CO23 was able to be transported through the blood-brain barrier. 
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